These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34381734)

  • 1. ME2 Promotes Proneural-Mesenchymal Transition and Lipogenesis in Glioblastoma.
    Yang M; Chen X; Zhang J; Xiong E; Wang Q; Fang W; Li L; Fei F; Gong A
    Front Oncol; 2021; 11():715593. PubMed ID: 34381734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-Hydroxy-7-oxo-5-heptenoic acid lactone is a potent inducer of brain cancer cell invasiveness that may contribute to the failure of anti-angiogenic therapies.
    Tomko N; Kluever M; Wu C; Zhu J; Wang Y; Salomon RG
    Free Radic Biol Med; 2020 Jan; 146():234-256. PubMed ID: 31715381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanisms of malic enzyme 2 in the tumorigenesis of human gliomas.
    Cheng CP; Huang LC; Chang YL; Hsieh CH; Huang SM; Hueng DY
    Oncotarget; 2016 Jul; 7(27):41460-41472. PubMed ID: 27166188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncostatin-M differentially regulates mesenchymal and proneural signature genes in gliomas via STAT3 signaling.
    Natesh K; Bhosale D; Desai A; Chandrika G; Pujari R; Jagtap J; Chugh A; Ranade D; Shastry P
    Neoplasia; 2015 Feb; 17(2):225-37. PubMed ID: 25748242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BYSL Promotes Glioblastoma Cell Migration, Invasion, and Mesenchymal Transition Through the GSK-3β/β-Catenin Signaling Pathway.
    Sha Z; Zhou J; Wu Y; Zhang T; Li C; Meng Q; Musunuru PP; You F; Wu Y; Yu R; Gao S
    Front Oncol; 2020; 10():565225. PubMed ID: 33178594
    [No Abstract]   [Full Text] [Related]  

  • 6. RBPJ contributes to the malignancy of glioblastoma and induction of proneural-mesenchymal transition via IL-6-STAT3 pathway.
    Zhang G; Tanaka S; Jiapaer S; Sabit H; Tamai S; Kinoshita M; Nakada M
    Cancer Sci; 2020 Nov; 111(11):4166-4176. PubMed ID: 32885530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Voxel-Based Radiographic Analysis Reveals the Biological Character of Proneural-Mesenchymal Transition in Glioblastoma.
    Qi T; Meng X; Wang Z; Wang X; Sun N; Ming J; Ren L; Jiang C; Cai J
    Front Oncol; 2021; 11():595259. PubMed ID: 33816228
    [No Abstract]   [Full Text] [Related]  

  • 8. USP10 deubiquitinates RUNX1 and promotes proneural-to-mesenchymal transition in glioblastoma.
    Qiu W; Xiao Z; Yang Y; Jiang L; Song S; Qi X; Chen Y; Yang H; Liu J; Chu L
    Cell Death Dis; 2023 Mar; 14(3):207. PubMed ID: 36949071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDK4/6 inhibition is more active against the glioblastoma proneural subtype.
    Li M; Xiao A; Floyd D; Olmez I; Lee J; Godlewski J; Bronisz A; Bhat KPL; Sulman EP; Nakano I; Purow B
    Oncotarget; 2017 Aug; 8(33):55319-55331. PubMed ID: 28903422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The PDK1/c‑Jun pathway activated by TGF‑β induces EMT and promotes proliferation and invasion in human glioblastoma.
    Luo D; Xu X; Li J; Chen C; Chen W; Wang F; Xie Y; Li F
    Int J Oncol; 2018 Nov; 53(5):2067-2080. PubMed ID: 30106127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The overexpression of GPX8 is correlated with poor prognosis in GBM patients.
    Li S; Jiang X; Guan M; Zhang Y; Cao Y; Zhang L
    Front Genet; 2022; 13():898204. PubMed ID: 36061208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of SOAT1 Suppresses Glioblastoma Growth via Blocking SREBP-1-Mediated Lipogenesis.
    Geng F; Cheng X; Wu X; Yoo JY; Cheng C; Guo JY; Mo X; Ru P; Hurwitz B; Kim SH; Otero J; Puduvalli V; Lefai E; Ma J; Nakano I; Horbinski C; Kaur B; Chakravarti A; Guo D
    Clin Cancer Res; 2016 Nov; 22(21):5337-5348. PubMed ID: 27281560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtype.
    Guadagno E; Vitiello M; Francesca P; Calì G; Caponnetto F; Cesselli D; Camorani S; Borrelli G; Califano M; Cappabianca P; Arra C; Crescenzi E; Cerchia L; De Caro MLDB; Fedele M
    Oncotarget; 2017 Aug; 8(35):59282-59300. PubMed ID: 28938636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Truncated Glioma-Associated Oncogene Homolog 1 (tGLI1) Mediates Mesenchymal Glioblastoma via Transcriptional Activation of CD44.
    Rimkus TK; Carpenter RL; Sirkisoon S; Zhu D; Pasche BC; Chan MD; Lesser GJ; Tatter SB; Watabe K; Debinski W; Lo HW
    Cancer Res; 2018 May; 78(10):2589-2600. PubMed ID: 29463580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proneural-Mesenchymal Transition: Phenotypic Plasticity to Acquire Multitherapy Resistance in Glioblastoma.
    Fedele M; Cerchia L; Pegoraro S; Sgarra R; Manfioletti G
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31167470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NOX2-Induced High Glycolytic Activity Contributes to the Gain of COL5A1-Mediated Mesenchymal Phenotype in GBM.
    Park Y; Park M; Kim J; Ahn J; Sim J; Bang JI; Heo J; Choi H; Cho K; Lee M; Moon JS; Lim J
    Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfer of MicroRNA via Macrophage-Derived Extracellular Vesicles Promotes Proneural-to-Mesenchymal Transition in Glioma Stem Cells.
    Zhang Z; Xu J; Chen Z; Wang H; Xue H; Yang C; Guo Q; Qi Y; Guo X; Qian M; Wang S; Qiu W; Gao X; Zhao R; Guo X; Li G
    Cancer Immunol Res; 2020 Jul; 8(7):966-981. PubMed ID: 32350000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma.
    Luedi MM; Singh SK; Mosley JC; Hassan ISA; Hatami M; Gumin J; Andereggen L; Sulman EP; Lang FF; Stueber F; Fuller GN; Colen RR; Zinn PO
    J Neurosurg; 2018 Dec; 129(6):1446-1455. PubMed ID: 29328002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear phosphorylated Y142 β-catenin accumulates in astrocytomas and glioblastomas and regulates cell invasion.
    Náger M; Santacana M; Bhardwaj D; Valls J; Ferrer I; Nogués P; Cantí C; Herreros J
    Cell Cycle; 2015; 14(22):3644-55. PubMed ID: 26654598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harnessing OLIG2 function in tumorigenicity and plasticity to target malignant gliomas.
    Kosty J; Lu F; Kupp R; Mehta S; Lu QR
    Cell Cycle; 2017 Sep; 16(18):1654-1660. PubMed ID: 28806136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.